NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/22/2024
Back to search
Official data from USPTO
PUMA BIOTECHNOLOGY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PUMA BIOTECHNOLOGY
ST13
US500000086686536Class
5
Filing
86686536
Registration
5486879
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/01/2025
Trademark type
Word
Nice classes
5
Filing date
07/08/2015
Registration date
06/05/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/22/2024
Last transaction
08/01/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/01/2018
First use in commerce
03/01/2018
Drawing code
4
Owner type
03
Owner location
Los Angeles, CA
Examiner
KHAN, AHSEN
Current location
Historical data usage
Holders and representatives
Holders
Puma Biotechnology, Inc.
Representatives
Douglas R. Wolf Wolf Greenfield & Sacks, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for the prevention and treatment of cancer
Publications
History of USPTO decisions and trademark events.
43 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/22/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/22/2024
E815
TEAS SECTION 8 & 15 RECEIVED
04/25/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/05/2023
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
06/05/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/28/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/27/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/05/2018
IUAF
USE AMENDMENT FILED
03/27/2018
EISU
TEAS STATEMENT OF USE RECEIVED
03/27/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/21/2017
EX3G
SOU EXTENSION 3 GRANTED
11/20/2017
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
11/20/2017
EXT3
SOU EXTENSION 3 FILED
11/15/2017
EEXT
SOU TEAS EXTENSION RECEIVED
11/15/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/12/2017
EX2G
SOU EXTENSION 2 GRANTED
07/10/2017
EXT2
SOU EXTENSION 2 FILED
07/10/2017
EEXT
SOU TEAS EXTENSION RECEIVED
07/10/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
11/30/2016
EX1G
SOU EXTENSION 1 GRANTED
11/28/2016
EXT1
SOU EXTENSION 1 FILED
11/28/2016
EEXT
SOU TEAS EXTENSION RECEIVED
11/28/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
07/12/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/17/2016
PUBO
PUBLISHED FOR OPPOSITION
05/17/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/27/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/04/2016
XAEC
EXAMINER'S AMENDMENT ENTERED
04/04/2016
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/04/2016
GNEA
EXAMINERS AMENDMENT E-MAILED
04/04/2016
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/04/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/31/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/30/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/08/2015
GNRT
NON-FINAL ACTION E-MAILED
10/08/2015
CNRT
NON-FINAL ACTION WRITTEN
10/08/2015
DOCK
ASSIGNED TO EXAMINER
10/08/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/13/2015
NWAP
NEW APPLICATION ENTERED
07/11/2015
Continuous trademark protection
Get notified about every new filing that threatens PUMA BIOTECHNOLOGY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.